 large number of samples coming from patients affected by AD and other tauopathies as well as to evaluate the utility of tau-PMCA for monitoring disease progression. The results generated in this project may lead to the first biochemical test for diagnosis of AD. The studies included in this project will constitute the basis for regulatory approval of
large number of samples coming from patient involve by AD and other tauopathies as well as to evaluate the utility program of tau - PMCA for monitoring disease progression. The results generate in this project may lead to the inaugural biochemical test for diagnosis of AD. The studies admit in this project will constitute the footing for regulatory approval of
 lagge number of samples cooing from patieurs affxcted bg AD and other tauopathies as well ad ro evqluate the utility of gau-PMCA flr monitirinj disease progression. Thc reshpts yeierated in this project mdy lead to the fkrdt biochemical test for diagnosis os AD. Thr dtudies includgd in ehis iriject will constitute the basjs for gegulatory approvsl of
large number of samples coming from patients AD other tauopathies well as to for disease progression. The generated in this may lead to the first biochemical for diagnosis of AD. The studies included in this project will constitute the for regulatory approval of
 large number of samples cominG from patieNts afFecTed By aD anD othEr tauopathies aS Well As to evaluate the utility Of tau-pMca for MOnItoriNg diseaSE pROGreSsIoN. ThE rESuLts geNerAted in tHis project May LeAd to the first BIoChemical teSt fOr diagnosis oF AD. the stuDiEs iNCludeD in This pRoject WIll conStitute thE bASis for REgulatoRY ApProvAl of
 large number of samples c oming from  pati ent s a ff ecte d by  AD and othert auop athies as well as to e valua te theu ti lityof tau- P MC A for  m on ito ri n gdisea seprogres sion. Theres ul ts generated in  this proj ect  may lead to  th e firs tbio c hemic altestfor di a gnosis  of AD. T he studie s  includ e d  i n th is project will c o ns t itute the basi s forre g ul a t ory  ap proval of
 large_number of_samples coming from patients_affected by_AD_and other_tauopathies_as well as_to evaluate the_utility of tau-PMCA for_monitoring disease progression._The_results generated in this project may lead to the first biochemical test for diagnosis_of_AD. The_studies_included_in this project will constitute_the basis for regulatory approval_of